{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T11:52:58Z","timestamp":1769946778790,"version":"3.49.0"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine & Pharmacotherapy"],"published-print":{"date-parts":[[2018,11]]},"DOI":"10.1016\/j.biopha.2018.08.027","type":"journal-article","created":{"date-parts":[[2018,8,29]],"date-time":"2018-08-29T16:12:00Z","timestamp":1535559120000},"page":"1277-1285","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":48,"special_numbering":"C","title":["Immunomodulatory effects of hydroxychloroquine on Th1\/Th2 balance in women with repeated implantation failure"],"prefix":"10.1016","volume":"107","author":[{"given":"H.","family":"Ghasemnejad-berenji","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Ghaffari Novin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Hajshafiha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Nazarian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.M.","family":"Hashemi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Ilkhanizadeh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Ghasemnejad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Sadeghpour","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Ghasemnejad-berenji","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.biopha.2018.08.027_bib0005","doi-asserted-by":"crossref","DOI":"10.1111\/aji.12766","article-title":"Successful treatment with intrauterine delivery of dexamethasone for repeated implantation failure","volume":"78","author":"Zhang","year":"2017","journal-title":"Am. J. Reprod. Immunol."},{"issue":"6","key":"10.1016\/j.biopha.2018.08.027_bib0010","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1080\/19396368.2017.1390007","article-title":"Regulatory T cells improve pregnancy rate in RIF patients after additional IVIG treatment","volume":"63","author":"Ahmadi","year":"2017","journal-title":"Syst. Biol. Reprod. Med."},{"issue":"1","key":"10.1016\/j.biopha.2018.08.027_bib0015","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.rbmo.2013.08.011","article-title":"Recurrent implantation failure: definition and management","volume":"28","author":"Coughlan","year":"2014","journal-title":"Reprod. Biomed. Online"},{"issue":"1","key":"10.1016\/j.biopha.2018.08.027_bib0020","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1111\/aji.12442","article-title":"Intravenous immunoglobulin G improves pregnancy outcome in women with recurrent pregnancy losses with cellular immune abnormalities","volume":"75","author":"Lee","year":"2016","journal-title":"Am. J. Reprod. Immunol."},{"issue":"4","key":"10.1016\/j.biopha.2018.08.027_bib0025","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1111\/aji.12338","article-title":"Immunosuppression with tacrolimus improved reproductive outcome of women with repeated implantation failure and elevated peripheral blood TH1\/TH2 cell ratios","volume":"73","author":"Nakagawa","year":"2015","journal-title":"Am. J. Reprod. Immunol."},{"issue":"1","key":"10.1016\/j.biopha.2018.08.027_bib0030","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1007\/s12016-016-8596-x","article-title":"Tumor necrosis factor-alpha and pregnancy: focus on biologics. An updated and comprehensive review","volume":"53","author":"Alijotas-Reig","year":"2017","journal-title":"Clin. Rev. Allergy Immunol."},{"issue":"4","key":"10.1016\/j.biopha.2018.08.027_bib0035","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1038\/ni.3131","article-title":"Immune mechanisms at the maternal-fetal interface: perspectives and challenges","volume":"16","author":"PrabhuDas","year":"2015","journal-title":"Nat. Immunol."},{"issue":"4","key":"10.1016\/j.biopha.2018.08.027_bib0040","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1093\/humrep\/deg156","article-title":"Increased T helper 1 cytokine responses by circulating T cells are present in women with recurrent pregnancy losses and in infertile women with multiple implantation failures after IVF","volume":"18","author":"Kwak\u2010Kim","year":"2003","journal-title":"Hum. Reprod."},{"issue":"6","key":"10.1016\/j.biopha.2018.08.027_bib0045","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1016\/j.rbmo.2015.08.009","article-title":"The pro-inflammatory and anti-inflammatory cytokine profile in peripheral blood of women with recurrent implantation failure","volume":"31","author":"Liang","year":"2015","journal-title":"Reprod. Biomed. Online"},{"issue":"6","key":"10.1016\/j.biopha.2018.08.027_bib0050","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1111\/j.1600-0897.2010.00946.x","article-title":"Degree of TNF\u2010\u03b1\/IL\u201010 cytokine elevation correlates with IVF success rates in women undergoing treatment with adalimumab (Humira) and IVIG","volume":"65","author":"Winger","year":"2011","journal-title":"Am. J. Reprod. Immunol."},{"key":"10.1016\/j.biopha.2018.08.027_bib0055","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1016\/j.biopha.2017.06.001","article-title":"Effect of Intravenous immunoglobulin on Th1 and Th2 lymphocytes and improvement of pregnancy outcome in recurrent pregnancy loss (RPL)","volume":"92","author":"Ahmadi","year":"2017","journal-title":"Biomed. Pharmacother."},{"issue":"4","key":"10.1016\/j.biopha.2018.08.027_bib0060","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.placenta.2014.02.004","article-title":"Potentiating maternal immune tolerance in pregnancy: a new challenging role for regulatory T cells","volume":"35","author":"Alijotas-Reig","year":"2014","journal-title":"Placenta"},{"key":"10.1016\/j.biopha.2018.08.027_bib0065","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1016\/j.biopha.2016.10.062","article-title":"Novel immunotherapeutic approaches for treatment of infertility","volume":"84","author":"Abdolmohammadi-Vahid","year":"2016","journal-title":"Biomed. Pharmacother."},{"issue":"1","key":"10.1016\/j.biopha.2018.08.027_bib0070","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1111\/aji.12320","article-title":"Increased circulating Th1\/Th2 ratios but not other lymphocyte subsets during controlled ovarian stimulation are linked to subsequent implantation failure after transfer of in vitro fertilized embryos","volume":"73","author":"Liang","year":"2015","journal-title":"Am. J. Reprod. Immunol."},{"issue":"1","key":"10.1016\/j.biopha.2018.08.027_bib0075","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1111\/aji.12493","article-title":"Unexplained recurrent miscarriage and recurrent implantation failure: is there a place for immunomodulation?","volume":"76","author":"Mekinian","year":"2016","journal-title":"Am. J. Reprod. Immunol."},{"issue":"1","key":"10.1016\/j.biopha.2018.08.027_bib0080","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.jns.2015.08.1525","article-title":"Hydroxychloroquine reduces microglial activity and attenuates experimental autoimmune encephalomyelitis","volume":"358","author":"Koch","year":"2015","journal-title":"J. Neurol. Sci."},{"issue":"1","key":"10.1016\/j.biopha.2018.08.027_bib0085","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.autrev.2014.08.040","article-title":"Obstetrical APS: is there a place for hydroxychloroquine to improve the pregnancy outcome?","volume":"14","author":"Mekinian","year":"2015","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.biopha.2018.08.027_bib0090","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jaut.2016.07.003","article-title":"Prevention & treatment of obstetrical complications in APS: is hydroxychloroquine the Holy Grail we are looking for?","volume":"75","author":"Meroni","year":"2016","journal-title":"J. Autoimmun."},{"issue":"5","key":"10.1016\/j.biopha.2018.08.027_bib0095","first-page":"857","article-title":"No histologic evidence of foetal cardiotoxicity following exposure to maternal hydroxychloroquine","volume":"35","author":"Friedman","year":"2017","journal-title":"Clin. Exp. Rheumatol."},{"issue":"3","key":"10.1016\/j.biopha.2018.08.027_bib0100","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1080\/14740338.2017.1269168","article-title":"Hydroxychloroquine in systemic lupus erythematosus (SLE)","volume":"16","author":"Ponticelli","year":"2017","journal-title":"Expert Opin. Drug Saf."},{"issue":"2","key":"10.1016\/j.biopha.2018.08.027_bib0105","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.ajog.2015.09.078","article-title":"The impact of hydroxychloroquine treatment on pregnancy outcome in women with antiphospholipid antibodies","volume":"214","author":"Sciascia","year":"2016","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"2","key":"10.1016\/j.biopha.2018.08.027_bib0110","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1111\/aji.12184","article-title":"Effect of hydroxychloroquine on antiphospholipid antibody\u2010induced changes in first trimester trophoblast function","volume":"71","author":"Albert","year":"2014","journal-title":"Am. J. Reprod. Immunol."},{"issue":"4","key":"10.1016\/j.biopha.2018.08.027_bib0115","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1080\/14767058.2017.1289511","article-title":"Treatment of preeclampsia with hydroxychloroquine: a review","volume":"31","author":"Abd Rahman","year":"2018","journal-title":"J. Maternal-Fetal Neonatal Med."},{"issue":"3","key":"10.1016\/j.biopha.2018.08.027_bib0120","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1038\/s41419-018-0378-3","article-title":"Hydroxychloroquine attenuates renal ischemia\/reperfusion injury by inhibiting cathepsin mediated NLRP3 inflammasome activation","volume":"9","author":"Tang","year":"2018","journal-title":"Cell Death Dis."},{"issue":"4","key":"10.1016\/j.biopha.2018.08.027_bib0125","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.autrev.2014.12.006","article-title":"Hydroxychloroquine as an anti-thrombotic in antiphospholipid syndrome","volume":"14","author":"Belizna","year":"2015","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.biopha.2018.08.027_bib0130","series-title":"SAT0027 Effect of Hydroxychloroquine on Disease Activity and Regulation of the Immune System in Systemic Lupus Erythematosus","author":"Monzavi","year":"2015"},{"key":"10.1016\/j.biopha.2018.08.027_bib0135","article-title":"Clinical and immunologic profiles in incomplete lupus erythematosus and improvement with hydroxychloroquine treatment","volume":"2016","author":"Olsen","year":"2016","journal-title":"Autoimmun. Dis."},{"issue":"6","key":"10.1016\/j.biopha.2018.08.027_bib0140","doi-asserted-by":"crossref","first-page":"766","DOI":"10.6061\/clinics\/2013(06)07","article-title":"Hydroxychloroquine decreases Th17-related cytokines in systemic lupus erythematosus and rheumatoid arthritis patients","volume":"68","author":"Silva","year":"2013","journal-title":"Clinics"},{"issue":"8","key":"10.1016\/j.biopha.2018.08.027_bib0145","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1177\/0961203312437270","article-title":"Effect of hydroxychloroquine treatment on pro-inflammatory cytokines and disease activity in SLE patients: data from LUMINA (LXXV), a multiethnic US cohort","volume":"21","author":"Willis","year":"2012","journal-title":"Lupus"},{"issue":"6","key":"10.1016\/j.biopha.2018.08.027_bib0150","doi-asserted-by":"crossref","first-page":"818","DOI":"10.3899\/jrheum.170737","article-title":"Hydroxychloroquine inhibits the differentiation of Th17 cells in systemic lupus erythematosus","volume":"45","author":"Yang","year":"2018","journal-title":"J. Rheumatol."},{"issue":"3","key":"10.1016\/j.biopha.2018.08.027_bib0155","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/S1083-8791(00)70058-9","article-title":"Hydroxychloroquine for the treatment of chronic graft-versus-host disease","volume":"6","author":"Gilman","year":"2000","journal-title":"Biol. Blood Marrow Transplant."},{"issue":"1","key":"10.1016\/j.biopha.2018.08.027_bib0160","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.bbmt.2011.05.016","article-title":"Randomized trial of hydroxychloroquine for newly diagnosed chronic graft-versus-host disease in children: a Children\u2019s Oncology Group study","volume":"18","author":"Gilman","year":"2012","journal-title":"Biol. Blood Marrow Transplant."},{"issue":"5","key":"10.1016\/j.biopha.2018.08.027_bib0165","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1517\/14740338.2011.566555","article-title":"Hydroxychloroquine in systemic lupus erythematosus and rheumatoid arthritis and its safety in pregnancy","volume":"10","author":"Abarientos","year":"2011","journal-title":"Expert Opin. Drug Saf."},{"issue":"2","key":"10.1016\/j.biopha.2018.08.027_bib0170","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.autrev.2004.11.009","article-title":"Safety of hydroxychloroquine in pregnant patients with connective tissue diseases. Review of the literature","volume":"4","author":"Costedoat-Chalumeau","year":"2005","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.biopha.2018.08.027_bib0175","first-page":"24","article-title":"Etanercept and immune treatment in multiple IVF failures","volume":"45","author":"Mangubat","year":"2001","journal-title":"Am. J. Reprod. Immunol."},{"issue":"5","key":"10.1016\/j.biopha.2018.08.027_bib0180","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1111\/j.1600-0897.2012.01179.x","article-title":"Die\u2010off ratio correlates with increased TNF\u2010\u03b1: IL\u201010 ratio and decreased IVF success rates correctable with Humira","volume":"68","author":"Winger","year":"2012","journal-title":"Am. J. Reprod. Immunol."},{"issue":"10","key":"10.1016\/j.biopha.2018.08.027_bib0185","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1080\/09513590.2016.1177012","article-title":"Pregnancy outcome following frozen embryo transfer after artificial cycle or treatment by clomiphene citrate","volume":"32","author":"Jouan","year":"2016","journal-title":"Gynecol. Endocrinol."}],"container-title":["Biomedicine & Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332218341155?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332218341155?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T02:28:40Z","timestamp":1766024920000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332218341155"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11]]},"references-count":37,"alternative-id":["S0753332218341155"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2018.08.027","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2018,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Immunomodulatory effects of hydroxychloroquine on Th1\/Th2 balance in women with repeated implantation failure","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2018.08.027","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}